Locations:
Search IconSearch

Neurosciences

Brain scan
July 20, 2020/COVID-19

Neurologic Manifestations of COVID-19: More Common Than We Thought (Podcast)

Mechanisms range from inflammation to infection of neurons

20-NEU-1918414-alzheimer-brain-650×450

Studies of an Alpha-1 Adrenergic Agonist for Alzheimer’s Advance With New NIA Grant

$2 million will enable preclinical dose and efficacy testing of “compound 3”

20-NEU-1901186_movement-disorders-COVID-19_650x450 (1)
July 6, 2020/COVID-19

COVID-19 and Movement Disorders: Time to Adopt ‘Adaptive Neurology’

Making the most of our evolving understanding of how the conditions intersect

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20-NEU-1916333 Sullivan podcast promo_CQD_650x450_CCC-1901608_06-03-20_736
July 1, 2020/Behavioral Health

Taming COVID-19-Inflamed Physician Burnout (Podcast)

How to practice self-care during a healthcare crisis

EEG monitoring
June 30, 2020/COVID-19

Continuous EEG Monitoring Reveals Seizures, Other Abnormalities in COVID-19 Patients

Acute symptomatic seizures detected in five of 22 patients monitored

19-NEU-6528_brain-tumor_650x450
June 25, 2020/Cancer/Research

Phase II Trial Evaluates Safety of Pembrolizumab plus SurVaxM in Recurrent Glioblastoma

Will cancer vaccine boost immunotherapy’s efficacy?

Pediatric rehab
June 25, 2020/COVID-19

Telemedicine for Pediatric Rehab: Success Is Possible in Inpatient and Outpatient Settings

Cleveland Clinic Children’s shares its learnings from the early days of COVID-19

Exercise
June 23, 2020/COVID-19

Five Common Questions About Physical Therapy in the COVID-19 Era

How to make PT safe and effective — in-person and at home

Nurses at computer
June 17, 2020/Neurosciences

Stroke Education Prevalence Rounds Ensure Compliance With Documentation

Compliance rates remain high five years after implementation

BackPage 51 of 77Next

Advertisement

Ad